J&J buys new-generation stent maker

Friday, 23 March 2007

In an effort to create a more powerful rival to Boston Scientific Corp., healthcare giant Johnson & Johnson said late Thursday night it would pay $1.4 billion for Conor Medsystems Inc. of California, developer of a new-generation stent to repair coronary arteries. (11/18/06)

 

< Prev		Next >